First evidence of anti-VEGF efficacy in an adult case of adamantinomatous craniopharyngioma: case report and illustrative review

CONCLUSIONS: To the best of our knowledge, our case is the first in the literature in which targeted therapy using anti-VEGF was successfully used as a single agent to treat adamantinomatous craniopharyngioma, with favorable outcome in terms of tumor shrinkage and clinical improvement. These preliminary results may open new perspectives for the management of adamantinomatous craniopharyngioma. Validation of this approach requires additional clinical evidence.PMID:37865272 | DOI:10.1016/j.ando.2023.10.003

Source: Annales d'Endocrinologie - October 21, 2023 Category: Endocrinology Authors: Andrea De Rosa Francesco Calvanese Fran çois Ducray Alexandre Vasiljevic Romain Manet Gerald Raverot Emmanuel Jouanneau Source Type: research